Publications by authors named "Jose M Priesca-Marin"
Splitting the Total Dose of Cyclophosphamide in Two Blocks Apart during the Conditioning of Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis Results in Diminished Cardiotoxicity: Experience in 1,000 Patients.
Rev Invest Clin
January 2022
Article Synopsis
- The study details the experience of conducting autografts for patients with autoimmune conditions, particularly multiple sclerosis, in a program based in Puebla and Monterrey, Mexico.
- The first transplant for multiple sclerosis occurred in 2006, and by December 2020, the program had autografted its 1,000th patient, indicating a significant increase in activity since 2015.
- Results demonstrated a meaningful improvement in patient disability scores across different types of multiple sclerosis, with high response rates observed after 12 months post-treatment, thereby providing valuable insights into the efficacy and safety of stem cell transplantation for autoimmune diseases.
Background: The ideal treatment of coronavirus disease (COVID)-19 has yet to be defined, but convalescent plasma (CoPla) has been successfully employed.
Objective: The objective of the study was to study the safety and outcomes of the administration of CoPla to individuals with severe COVID-19 in an academic medical center.
Methods: Ten patients were prospectively treated with plasma from COVID-19 convalescent donors.
Background: Thrombotic thrombocytopenic purpura (TTP) is a hematologic disease that can be fatal if not treated early. We aimed to describe the clinical characteristics of Mexican patients with idiopathic TTP.
Study Design And Methods: We conducted a retrospective study, including all adult patients diagnosed with idiopathic TTP from 2011 to 2017 in two Mexican centers.